HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Strategies for successful left-lobe living donor liver transplantation in 250 consecutive adult cases in a single center.

AbstractBACKGROUND:
Living donor liver transplantation (LDLT) using left-lobe grafts was not generally recognized as feasible due to the problem of graft size.
STUDY DESIGN:
We retrospectively evaluated strategies for successful left-lobe LDLT in 250 consecutive cases stratified into 2 eras: Era 1 (n = 121), in which surgical procedures were continually refined, and Era 2 (n = 129), in which established procedures were used.
RESULTS:
Graft volume (GV) did not affect the incidence of graft function or survival. Era 2 patients had decreased portal vein (PV) pressure at closure (16.0 ± 3.5 mmHg vs 19.1 ± 4.6 mmHg, p < 0.01), increased PV flow/GV (301 ± 125 mL/min/100g vs 391 ± 142 mL/min/100g, p < 0.01), and improved graft survival rate (1-year: 90.6% vs 81.8%. p < 0.01) despite the smaller GV/standard volume (SLV) ratio (36.2% ± 5.2% vs 41.2% ± 8.8%, p < 0.01) compared with Era 1. Patients in Era 2 had lower PV pressure and greater PV flow (y = 598-5.7 x, p = 0.02) at any GV/SLV compared with cases in Era 1 (y = 480-4.3 x, p < 0.01), representing greater graft compliance. Univariate analysis for graft survival showed that Era 1, Model for End-Stage Liver Disease (MELD) score ≥ 20, inpatient status, closing portal venous pressure ≥ 20 mmHg, no splenectomy, and operative blood loss ≥ 10 L were the risk factors for graft loss, and multivariate analysis showed that Era 1 was the only significant factor (p < 0.01). During Era 2, development of primary graft dysfunction was associated with inpatient recipient status (p = 0.02) and donor age ≥ 45 years (p < 0.01).
CONCLUSIONS:
The outcomes of left-lobe LDLT were improved by accumulated experience and technical developments.
AuthorsToru Ikegami, Ken Shirabe, Yuji Soejima, Tomoharu Yoshizumi, Hideaki Uchiyama, Yo-ichi Yamashita, Norifumi Harimoto, Takeo Toshima, Shohei Yoshiya, Tetsuo Ikeda, Yoshihiko Maehara
JournalJournal of the American College of Surgeons (J Am Coll Surg) Vol. 216 Issue 3 Pg. 353-62 (Mar 2013) ISSN: 1879-1190 [Electronic] United States
PMID23318119 (Publication Type: Journal Article)
CopyrightCopyright © 2013. Published by Elsevier Inc.
Topics
  • Adult
  • Graft Survival
  • Humans
  • Liver Transplantation (methods)
  • Living Donors
  • Multivariate Analysis
  • Portal Vein (physiopathology)
  • Primary Graft Dysfunction (epidemiology)
  • Retrospective Studies
  • Risk Factors
  • Splenectomy
  • Treatment Outcome
  • Venous Pressure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: